Citi training exam review - Study guides, Class notes & Summaries

CITI Training Exam Review Questions With Complete Solutions Latest Update (Graded A+). What is the timeline of drug development? Correct Answer: Preclinical trials, IND Submission, Clinical Development (Phase I-III), NDA submission, Marketing (Phase IV) When does a sponsor submit the IND? Correct Answer: Prior to clinical development phases (human trials). *30 day process. What is the NDA? Correct Answer: New Drug Application, submitted prior to Phase IV marketing phase. How long does th...

CITI TRAINING Exam Review Questions and answers/ An example of an institutional COI is: - -An industry sponsor pays for the construction of a new research laboratory at the organization The peer review process can create conflicts of interest because the choice of who reviews a potentially publishable project may show: - -There may be bias by the peer reviewer as to the area of research During an Institutional Review Board (IRB) meeting, any IRB member who may have a potential COI with ...

CITI Training Exam Review questions and answers, rated A+ A subject participates in a drug study because treatment is available at no or reduced cost, and he could not otherwise afford it. This is an example of A. Institutional vulnerability B. Communicative vulnerability C. Economic vulnerability D. Social vulnerability - -C. Economic vulnerability According to the authors, there are four common abuses that historically are described as giving rise to vulnerability . Which response ...

Citi Training Exam Review Questions and answers, rated A+/ Why are institutionally provisioned technology systems (in other words, systems provided through a university, hospital, or clinic) generally more secure than consumer products? - -Because information technology professionals have vetted them with the vendor. When would an IRB consider the risks of a study to be controlled? - -When there is an appropriate risk mitigation and management plan in place. What existing federal regu...

CITI training Exam Review Questions and answers, VERIFIED. A covered entity may use or disclose PHI without an authorization, or documentation of a waiver or an alteration of authorization, for all of the following EXCEPT: - -Data that does not cross state lines when disclosed by the covered entity. Under HIPAA, a "disclosure accounting" is required: - -For all human subjects research that uses PHI without an authorization from the data subject, except for limited data sets. When re...

Collaborative Institutional Training Initiative (CITI) Training Review Exam Q&As

CITI TRAINING IRB PROTOCOL REVIEW COMPLETED EXAM WITH RATIONALES 2024

CITI Training Review Human Subjects Research Exam Questions with Complete Solutions.

CITI Training Review Human Subjects Research Exam Questions with Correct Answers